Colon News and Research

RSS

Racial disparities exist for black and Hispanic patients undergoing major surgeries in U.S. hospitals

Considerable racial disparities exist in surgical outcomes for black and Hispanic patients undergoing major cancer and non-cancer surgeries in U.S. hospitals, even among institutions that have already enrolled in a national surgical quality improvement initiative.

9 Dec 2015

RTFCCR grant supports ASCOLT study that evaluates effectiveness of Aspirin in colorectal cancer patients

Rising Tide Foundation for Clinical Cancer Research, an international private foundation based in Switzerland, has awarded a US $800,000 grant to be released over two years for the ASCOLT study conducted by Dr John Chia, Senior Consultant Medical Oncologist at the Division of Medical Oncology, National Cancer Centre Singapore.

9 Dec 2015

Scientists reveal why loss of CD73 enzyme in human cancer promotes tumor progression

Scientists have shown for the first time why loss of the enzyme CD73 in human cancer promotes tumor progression.

8 Dec 2015

Novel anticancer agent appears to have greater potency, longer efficacy than irinotecan and topotecan

In the five decades since camptothecin was first isolated from the bark of a tree used in traditional Chinese medicine and identified as a powerful anticancer agent, several thousand chemicals with similar structures and functions have been investigated. And while two of these analog compounds, irinotecan and topotecan, have been approved in the U.S. as treatments for cancer, both are associated with significant shortcomings.

26 Nov 2015

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.

23 Nov 2015

NYC’s colorectal cancer screening rates boosted and racial disparities eliminated

A concerted effort to increase colorectal cancer screening rates led to a dramatic increase in NYC screening colonoscopy rates among average-risk men and women and eliminated racial/ethnic disparities in screening

23 Nov 2015

New coalition formed to boost colorectal cancer screening rates in New York City

A coalition formed by the New York City Department of Health and Mental Hygiene which included a team from Mount Sinai to increase colorectal cancer screening rates in New York City resulted in a 40 percent increase in screening rates over four years.

23 Nov 2015

Researchers suggest new way to target cancer protein

For years, scientists have struggled to find a way to block a protein known to play an important role in many cancers. The protein, STAT3, acts as a transcription factor -- it performs the crucial task of helping convert DNA into the RNA instructions used to make new proteins.

19 Nov 2015

Identifying new mechanism for aspirin in cancer prevention

Aspirin has been shown to decrease the risk of colorectal cancer and possibly other cancers. However, the risk of side effects, including in some cases severe gastrointestinal bleeding, makes it necessary to better understand the mechanisms by which aspirin acts at low doses before recommending it more generally as a preventative, says Cornelia Ulrich, PhD, Senior Director of Population Sciences at Huntsman Cancer Institute in Salt Lake City.

19 Nov 2015

New approach helps Group Health to increase rates of lifesaving screening for colon cancer

Mailing yearly stool kits--an alternative to the often-dreaded colonoscopy--has helped Group Health to boost rates of lifesaving screening for colon cancer, according to new research from Group Health Research Institute.

17 Nov 2015

IASLC commends FDA's decision to grant accelerated approval for new lung cancer therapy

The International Association for the Study of Lung Cancer commends the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval for osimertinib (Tagrisso), an oral medication for advanced non-small cell lung cancer (NSCLC) patients with a specific epidermal growth factor receptor (EGFR) mutation (T790M) and following progression after previous EGFR inhibitor therapies.

17 Nov 2015

EU-funded research project aims to reduce oxidation in processed meat products

An EU-funded research project is to make sausages, patties and other meat products healthier in the future. Researchers at Lund University in Sweden, the Swedish University of Agricultural Sciences (SLU) and four other European research institutions have launched a joint project to reduce the risk of colon cancer - the most common cancer of the gastrointestinal tract in Sweden.

13 Nov 2015

New RNA test of blood platelets can be used to detect location of cancer

A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood. Using this new method for blood-based RNA tests of blood platelets, researchers have been able to identify cancer with 96 per cent accuracy. This according to a study at Umeå University in Sweden recently published in the journal Cancer Cell.

12 Nov 2015

Sausages With Antioxidants From Berries To Prevent Cancer

An EU-funded research project is to make sausages, patties and other meat products healthier in the future.

11 Nov 2015

New findings reveal association between colorectal cancer and melanoma drug treatment

Veteran cancer reseacher Prof. Emeritus Alexander Levitzki of Hebrew University of Jerusalem says new findings show link between colorectal cancer and melanoma drug treatment knoqwn as "NT157" in two recently published studies in journal, "Ocogene."

10 Nov 2015

Cancer survivors' journeys chronicled by Bethlehem artist and cancer survivor Susan Schaffer

Chronicling the journeys of cancer survivors, friends and family has been an emotional process, one filled with joy and shared sorrow for Bethlehem artist and cancer survivor Susan H. Schaffer. As part of her Visions of Hope series of acrylic paintings, Susan offers insight into the windows of the soul - her collection captures the eyes of the people willing to share their respective cancer journeys with her.

9 Nov 2015

NTU Singapore scientists harness dead bacteria to destroy colon tumours cells effectively

Scientists from Nanyang Technological University have successfully used dead bacteria to kill colorectal cancer cells. Harvesting the Clostridium sporogenes bacteria found commonly in soil, the NTU team was able to harness the bacteria in its dead form, and its secretions, to destroy colon tumours cells effectively.

9 Nov 2015

Colon News and Research

Racial disparities exist for black and Hispanic patients undergoing major surgeries in U.S. hospitals

RTFCCR grant supports ASCOLT study that evaluates effectiveness of Aspirin in colorectal cancer patients

Scientists reveal why loss of CD73 enzyme in human cancer promotes tumor progression

Novel anticancer agent appears to have greater potency, longer efficacy than irinotecan and topotecan

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

NYC’s colorectal cancer screening rates boosted and racial disparities eliminated

New coalition formed to boost colorectal cancer screening rates in New York City

Researchers suggest new way to target cancer protein

Identifying new mechanism for aspirin in cancer prevention

New approach helps Group Health to increase rates of lifesaving screening for colon cancer

IASLC commends FDA's decision to grant accelerated approval for new lung cancer therapy

EU-funded research project aims to reduce oxidation in processed meat products

New RNA test of blood platelets can be used to detect location of cancer

Sausages With Antioxidants From Berries To Prevent Cancer

New findings reveal association between colorectal cancer and melanoma drug treatment

Cancer survivors' journeys chronicled by Bethlehem artist and cancer survivor Susan Schaffer

NTU Singapore scientists harness dead bacteria to destroy colon tumours cells effectively

Utah chemists devise new way to detect DNA damage

PCSG campaign highlights significance of family doctors in early gastroenterological cancer diagnosis

Researchers team up to evaluate biological and genetic differences of GI cancers in race, ethnicity

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News